Pathogenic germline mutations in BRCA1 (n = 10) or BRCA2 (n = 10) were detected retrospectively in a biobank research setting, 5–7 years after breast cancer diagnosis, in 20 out of 273 breast cancer patients [27]. This evidence concerns the gene BRCA1 and breast cancer.